Recombinant human single chain Fv antibodies recognizing human interleukin-6 - Specific targeting of cytokine-secreting cells

被引:24
作者
Krebs, B
Griffin, H
Winter, G
Rose-John, S
机构
[1] Johannes Gutenberg Univ Mainz, Dept Med, Sect Pathophysiol, D-55101 Mainz, Germany
[2] Univ Cambridge, Ctr Prot Engn, MRC, Cambridge CB2 2QH, England
关键词
D O I
10.1074/jbc.273.5.2858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A human antibody library was displayed on the surface of filamentous bacteriophage and screened for binding to human interleukin-6 (IL-6). Two antibody-bearing phages were selected that bound IL-6. The complementary-determining region 3 loops of the variable heavy chains of these two antibodies differed in length and sequence and recognized two distinct epitopes. One of the single chain Fv fragments isolated (H1) was found to bind human (but not murine) IL-6 with an affinity comparable to that of the human IL-6 receptor. HI also recognized newly synthesized human IL-6 intracellularly, as shown by indirect immunofluorescence. H1 did not neutralize human IL-6, and the H1 epitope was mapped to a region of IL-6 not involved in interactions with IL-6, IL-6 receptor, or the signal-transducing protein gp130. To target IL-6-secreting cells, we then constructed a bispecific antibody fragment (a diabody) comprising H1 and the antigen binding site of the T-cell activating monoclonal antibody OKT3. The diabody led to T-cell-mediated killing of cells secreting IL-6.
引用
收藏
页码:2858 / 2865
页数:8
相关论文
共 46 条
[1]   PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES [J].
AARDEN, LA ;
DEGROOT, ER ;
SCHAAP, OL ;
LANSDORP, PM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1411-1416
[2]   Enterobacteria-infected T cells as antigen-presenting cells for cytotoxic CD8 T cells: A contribution to the self-limitation of cellular immune reactions in reactive arthritis? [J].
Ackermann, B ;
Staege, MS ;
ReskeKunz, AB ;
Dienes, HP ;
zumBuschenfelde, KHM ;
MarkerHermann, E .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1121-1127
[3]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[4]   INTERLEUKIN-6 IN CLINICAL MEDICINE [J].
BAUER, J ;
HERRMANN, F .
ANNALS OF HEMATOLOGY, 1991, 62 (06) :203-210
[5]  
BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561
[6]  
BRAKENHOFF JPJ, 1989, J IMMUNOL, V143, P1175
[7]  
BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86
[8]   FATE OF INTERLEUKIN-6 IN THE RAT - INVOLVEMENT OF SKIN IN ITS CATABOLISM [J].
CASTELL, J ;
KLAPPROTH, J ;
GROSS, V ;
WALTER, E ;
ANDUS, T ;
SNYERS, L ;
CONTENT, J ;
HEINRICH, PC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 189 (01) :113-118
[9]   MAKING ANTIBODY FRAGMENTS USING PHAGE DISPLAY LIBRARIES [J].
CLACKSON, T ;
HOOGENBOOM, HR ;
GRIFFITHS, AD ;
WINTER, G .
NATURE, 1991, 352 (6336) :624-628
[10]   DEVELOPMENT OF AN INTERLEUKIN (IL)-6 RECEPTOR ANTAGONIST THAT INHIBITS IL-6-DEPENDENT GROWTH OF HUMAN MYELOMA CELLS [J].
DEHON, FD ;
EHLERS, M ;
ROSEJOHN, S ;
EBELING, SB ;
BOS, HK ;
AARDEN, LA ;
BRAKENHOFF, JPJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2395-2400